Skip to main content

Advertisement

Log in

Validation of a Soft Tissue Sarcoma Nomogram Using a National Cancer Registry

  • Bone and Soft Tissue Sarcomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

A nomogram to predict disease-specific mortality (DSM) following surgery for soft tissue sarcoma (STS) has been developed by the Memorial Sloan Kettering Cancer Center (MSKCC). The goal of this study was to validate this nomogram by assessing discrimination and calibration at the population level using a national cancer database.

Methods

Retrospective review of the Surveillance, Epidemiology, and End Results cancer registries identified patients undergoing surgery for STS from 1988 to 2011. Data for patient age, tumor size, tumor grade, histologic subtype, sex, primary tumor location, and tumor depth were entered into the nomogram calculator for each patient. Discrimination was quantified using a concordance index. Calibration was assessed by comparing quintiles of nomogram-predicted probabilities of disease-specific mortality (DSM) with American Joint Committee on Cancer (AJCC) stage DSM.

Results

Overall, 9237 patients were identified with complete information needed for the nomogram. With a mean follow-up of 45 months, the concordance index for nomogram-predicted DSM with actual DSM was 0.74 for the entire cohort. For low- and high-grade tumors, this was 0.71 and 0.66, respectively. Kaplan–Meier curves showed better calibration for nomogram-predicted DSM when compared with AJCC staging.

Conclusions

Our results validate the use of the MSKCC STS nomogram in the general population, with better predictive ability than AJCC staging. However, a concordance index of 0.74 suggests that further improvement in prognostication is needed, perhaps with biological markers or additional clinical variables.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–41.

    Article  PubMed  Google Scholar 

  2. Nedea EA, DeLaney TF. Sarcoma and skin radiation oncology. Hematol Oncol Clin North Am. 2006;20(2):401–29.

    Article  PubMed  Google Scholar 

  3. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds). AJCC cancer staging manual. 7th ed. New York: Springer; 2010.

    Google Scholar 

  4. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (eds). AJCC cancer staging manual. 6th ed. New York: Springer; 2002.

    Google Scholar 

  5. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20(3):791–6.

    Article  PubMed  Google Scholar 

  6. Eilber FC, Brennan MF, Eilber FR, Dry SM, Singer S, Kattan MW. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer. 2004;101(10):2270–5.

    Article  PubMed  Google Scholar 

  7. Mariani L, Miceli R, Kattan MW, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005;103(2):402–8.

    Article  PubMed  Google Scholar 

  8. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. http://www.seer.cancer.gov. Accessed date Dec 2014.

  9. Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113(3):573–81.

    Article  PubMed  Google Scholar 

  10. Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997;15(1):350–62.

    PubMed  CAS  Google Scholar 

  11. Parsons HM, Habermann EB, Tuttle TM, Al-Refaie WB. Conditional survival of extremity soft-tissue sarcoma: results beyond the staging system. Cancer. 2011;117(5):1055–60.

    Article  PubMed  Google Scholar 

Download references

Disclosure

Sanjay P. Bagaria, Amy E. Wagie, Richard J. Gray, Barbara A. Pockaj, Steven Attia, Elizabeth B. Habermann, and Nabil Wasif have no disclosures to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanjay P. Bagaria MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bagaria, S.P., Wagie, A.E., Gray, R.J. et al. Validation of a Soft Tissue Sarcoma Nomogram Using a National Cancer Registry. Ann Surg Oncol 22 (Suppl 3), 398–403 (2015). https://doi.org/10.1245/s10434-015-4849-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-015-4849-9

Keywords

Navigation